Lupus: A Discussion of Symptoms and Treatment
November 6, 2017
Treatment Options and Clinical Trial for the Autoimmune Disease
Lupus, which is also referred to as System Lupus Erythematosus (SLE), is a chronic, complex and often disabling disorder. According to the Lupus Foundation of America, the disease affects at least 1.5 million people in the United States, mostly women. An autoimmune disease, lupus triggers the body to attack its own cells and organs, including the skin, joints, heart, lungs, blood, kidneys, and brain. The bodies of lupus sufferers can’t differentiate between foreign germs and viruses and healthy cells. Lupus nephritis (LN) in an inflammation of the kidney that represents a serious progression of SLE. It is estimated that as many as 60% of all SLE patients have or will have clinical LN requiring treatment.
Join us as The Balancing Act discusses lupus and lupus nephritis with Dr. William Pendergraft from UNC Kidney Center, hears from patients who suffer from the disease, and looks at the latest clinical trials that are providing some hope for patients.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.